Close Menu

NEW YORK (GenomeWeb) – Vela Diagnostics said today that its Sentosa SX Cell-free DNA Kit is now CE marked for in vitro diagnostics use.

The kit is designed to run on the Sentosa SX101 instrument, and enables extraction of circulating cfDNA from human plasma, for use in next-gen sequencing and real-time PCR workflows.

According to Vela, its technology has a high recovery efficiency for DNA fragments of about 170bp, and allows the recovery of low-frequency variants. Automated sample extraction takes approximately 3.5 hours with 20 minutes of operator hands-on time.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Apr
09
Sponsored by
Sophia Genetics

This webinar will present the utility of a personalized in silico analytical approach for the routine clinical diagnosis of channelopathies and cardiomyopathies. 

Apr
11
Sponsored by
Bionano Genomics

This webinar will review a recent study that applied whole-genome sequencing and optical genome mapping to identify a large number of previously undetected somatic structural variants in leukemia samples.